EXPECTED TURNAROUND TIME 

24 Hours 

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

SPECIMEN REQUIREMENTS 

SPECIMEN
Nasopharyngeal Swab

VOLUME
3 mL (minimum volume- 1mL)

CONTAINER
The Bio Teke Viral Transport Device

STORAGE INSTRUCTIONS 
Refrigerated (2-8 °C)

STABILITY REQUIREMENTS 
7 days at 2-8 °C and 14 days at -70°C or lower. Avoid repeated freezing and thawing. 

TEST DETAILS

METHODOLOGY
PCR

REFERENCE RANGE 
Detected or Not Detected

STATEMENT ON MEDICAL NECESSITY 
Sexually transmitted diseases (STDs) represent a significant public health concern due to their potential to cause serious health complications if left untreated. STDs can lead to a range of issues including infertility, chronic pain, and increased susceptibility to HIV. Early detection and management are crucial for effective treatment and to prevent transmission to others. All ordered tests should be medically necessary for the diagnosis or detection of disease, illness, impairment, symptom, syndrome, or disorder and the results should be used in the medical management and treatment decisions for the patient. Alliance Laboratories requires ICD-10 codes with each order for lab testing and both the tests ordered and the diagnosis should be documented. The United States Department of Health and Human Services, Office of Inspector General, takes the position that a provider who orders medically unnecessary tests may be subject to civil penalties.

PANELS AND PROFILES
Alliance Laboratories offers Providers the convenience of ordering test combinations in a group at times with the flexibility to choose appropriate test(s) for individual patients. Providers should only order those tests that he or she believes are medically necessary for each patient, and a
lesser inclusive profile or individual tests should be ordered if not all tests in the test combination/profile are medically necessary. All tests offered in a test combination/profile may be ordered separately as individual tests. Alliance Laboratories Sexually Transmitted Diseases (STDs) Panel consist of 14 organisms and 4 antibiotic resistance targets manufactured with the fluidity to formulate custom panels. Alliance Laboratories encourages clients to contact their Alliance representative if the testing panel shown do not meet individual needs for any reason, or if some other combination of procedures is needed.

CPT CODES
CPT Codes listed are in accordance with Current Procedural Terminology, a publication of the American Medical Association. CPT codes are the responsibility of the billing party and are listed here for informational purposes. Correct coding may vary from one carrier to another. Alliance Laboratories may bill specific carriers using codes other than what is shown.

• REQUISITION
• SAMPLE REPORT
• PROFILE/PANEL

EXPECTED TURNAROUND TIME 

24 Hours 

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

SPECIMEN REQUIREMENTS 

SPECIMEN 
Fecal swab or Fecal Specimen

CONTAINER
Fecal swab Collection, transport and preservation System

STORAGE INSTRUCTIONS 
Room temperature 24-48 hours; Refrigerated (2-8 °C) 48-72 hours.

STABILITY REQUIREMENTS 
7 days at 2-8 °C and 14 days at -70°C or lower. Avoid repeated freezing and thawing. 

TEST DETAILS

METHODOLOGY
PCR

REFERENCE RANGE 
Detected or Not Detected

STATEMENT OF MEDICAL NECESSITY 
All ordered tests should be medically necessary for the diagnosis or detection of disease, illness, impairment, symptom, syndrome, or disorder and the results should be used in the medical management and treatment decisions for the patient. Alliance Laboratories requires ICD-10 codes with each order for lab testing and both the tests ordered, and the diagnosis should be documented in the provider’s medical record for the patient. Gastrointestinal panels are critical in diagnosing infectious and non-infectious conditions affecting the gastrointestinal tract. Accurate identification of pathogens and other abnormalities is essential for effective treatment, preventing complications, and managing symptoms. GI panels help in distinguishing between different causes of gastrointestinal illness, which can lead to appropriate and targeted therapeutic interventions. The gastrointestinal panel is a crucial diagnostic tool for identifying the causes of gastrointestinal symptoms and guiding appropriate treatment. By providing comprehensive information about potential pathogens and abnormalities, the panel supports targeted therapy, enhances patient care, and aids in the effective management of gastrointestinal conditions. The United States Department of Health and Human Services, Office of Inspector General, takes the position that a provider who orders medically unnecessary tests may be subject to civil penalties.

PANELS AND PROFILES
Targets Included
Adenovirus
Astrovirus
Campylobacter spp
Clostridium difficile
Cryptosporidium spp
Dientamoeba fragilis
Entamoeba histolytica
Enteroaggregative E. coli
Enterohemorrhagic E. coli
Enteroinvasive E. coli (Shigella)
Enteropathogenic E. coli
Enterotoxigenic E. coli
Escherichia coli (O157)
Giardia lamblia
Helicobacter pylori
Norovirus G1
Norovirus G2
Plesiomonas Shigelloides
Rotavirus
Salmonella spp
Sapovirus
Shigella spp
Vibrio cholerae
Yersinia enterocolitica

Alliance Laboratories offers Providers the convenience of ordering test combinations in a group at times with the flexibility to choose appropriate test(s) for individual patients. Providers should only order those tests that he or she believes are medically necessary for each patient, and a lesser inclusive profile or individual tests should be ordered if not all tests in the test combination/profile are medically necessary. All tests offered in a test combination/profile may be ordered separately as individual tests. Alliance Laboratories encourages clients to contact their Alliance representative if the testing configurations shown do not meet individual needs for any reason, or if some other combination of procedures is needed.

CPT CODES
CPT Codes listed are in accordance with Current Procedural Terminology, a publication of the American Medical Association. CPT codes are the responsibility of the billing party and are listed here for informational purposes. Correct coding may vary from one carrier to another. Alliance laboratories may bill specific carriers using codes other than what is shown.

• REQUISITION
• SAMPLE REPORT
• PROFILE/PANEL

EXPECTED TURNAROUND TIME 

24-48 Hours 

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

SPECIMEN REQUIREMENTS 

SPECIMEN
Clipped Nail

VOLUME
2 mL (minimum volume 1 mL)

CONTAINER
Sterile Nail collection tube

STORAGE INSTRUCTIONS
Room temp. 6 days, Refrigerated 6 days

TEST DETAILS

METHODOLOGY
PCR

REFERENCE RANGE 
Detected or Not Detected

ADDITIONAL INFORMATION
Nail fungal infections (Nail Microbiota) are a group of infectious diseases where it is important to identify the pathology of nail deformation and determine a proper treatment plan. Fungi can infect almost any part of the body; however, these infections are most observed in the skin and nails, mainly on the foot. Nail fungal infections or onychomycosis are estimated to occur in over a billion people each year. It is the cause of roughly 50% of nail deformities and affects approximately 14-18% of adults. Anyone can acquire these infections, but the elderly and critically ill are often the most who commonly suffer. Real-time PCR OpenArray™ testing is important because conditions of psoriasis and malignant melanoma can mimic the appearance of fungal infections. A large proportion of Nail Microbiotas are asymptomatic or sub-clinical and hence go undiagnosed. Accurate and prompt identification of nail microbiota is the key to proper infection management for patients suffering from fungal and other pathogenic infections. Chronic nail infections often involve multiple organisms. The presence of these organisms is found extensively in the fungal group, which plays a substantial role in delayed healing, increased complications, and poor outcomes. Most skin fungal pathogens are colonized in both aerobic and anaerobic environments. Chronic nail fungal and other pathogen infections may cause substantial morbidity and are costly to treat. Several microorganisms are known to play a role in nail infections. For the successful treatment of nail microbiota, especially fungi, there is a need for precise and robust diagnostic methods. This test utilizes real-time PCR amplification to detect the presence of a microorganism in a nail sample by amplifying the genomic DNA of the organism. The TaqMan™ OpenArray™ nail microbiota assay is efficient and easy-to-use for the characterization of key nail microbial targets through real-time PCR. TaqMan™ OpenArray™ testing is fast and robust to contamination. This real-time PCR OpenArray™ test is ideal for the identification of these infections. Diagnostic methods that utilize fungal colonization/cultural identification can be time-consuming and may not completely illustrate all present pathogens due to the lack of sensitivity of the method created by the competition of multiple organisms in a single sample. TaqMan™ OpenArray™ testing (quantitative PCR, qPCR) has become an established method for rapid detection, quantification, and identification of microbial agents over the past decade. TaqMan™ OpenArray™ testing uses increased sensitivity and specificity to support the more accurate diagnosis of crucial infections, or lack thereof, to properly treat chronic fungal infections with faster turnaround times. Panel-based molecular testing not only help identify the presence of specific species but also profile Nail Microbiota pathogenic organisms, which would help understand its biological significance and may potentially provide guidance and reducing over-treatment. Microorganism‐specific TaqMan™ Assays offer a rapid and accurate approach to investigate and monitor Nail Microbiota microbiome composition and dynamics.

REFERENCES
1. “DNA Sequencing to Evaluate Nail Pathogens: An Investigation into Bacteria and Fungi”, NCBI, 2021 https://pubmed.ncbi.nlm.nih.gov/33872357/
2. “Characterization of the nail microbiome in psoriatic and non-psoriatic patients with onychomycosis”, NCBI, 2022 https://pubmed.ncbi.nlm.nih.gov/34549836/

STATEMENT OF MEDICAL NECESSITY 
All ordered tests should be medically necessary for the diagnosis or detection of disease, illness, impairment, symptom, syndrome, or disorder and the results should be used in the medical management and treatment decisions for the patient. Alliance Laboratories requires ICD-10 codes with each order for lab testing and both the tests ordered, and the diagnosis should be documented in the provider’s medical record for the patient. Nail fungus infections, or onychomycosis, can cause significant discomfort, cosmetic concerns, and functional impairments. Accurate diagnosis is essential because the treatment varies depending on the type of fungus involved. A nail fungus panel provides precise identification of the fungal pathogen, which is necessary for effective and targeted treatment. A nail fungus panel is a vital diagnostic tool for accurately identifying fungal pathogens involved in nail infections. It allows for precise treatment decisions, improving the effectiveness of therapy and reducing the risk of persistent or recurrent infections. Early and accurate diagnosis facilitates better patient outcomes and effective management of nail fungal infections. The United States Department of Health and Human Services, Office of Inspector General, takes the position that a provider who orders medically unnecessary tests may be subject to civil penalties.

PANELS AND PROFILES
Targets Included
Acremonium strictum
Alternaria_alternata
Aspergillus fumigatus
Aspergillus niger
Aspergillus terreus
Aspergillus versicolor
Candida albicans
Candida parapsilosis
Curvularia lunata
Epidermophyton floccosum
Fusarium solani
Geotrichum candidum
Microsporum audouinii
Microsporum canis
Microsporum gypseum
Microsporum nanum
Pichia onychis
Sarcoptes scabiei
Scopulariopsis brevicaulis
Neoscytalidium dimidiatum
Trichophyton interdigitale, Trichophyton mentagrophytes
Trichophyton rubrum
Trichophyton soudanense
Trichophyton interdigitale, Trichophyton mentagrophytes
Trichophyton violaceum
Trichosporon beigelii
Trichosporon mucoides
Zygosaccharomyces spp

Alliance Laboratories offers Providers the convenience of ordering test combinations in a group at times with the flexibility to choose appropriate test(s) for individual patients. Providers should only order those tests that he or she believes are medically necessary for each patient, and a lesser inclusive profile or individual tests should be ordered if not all tests in the test combination/profile are medically necessary. All tests offered in a test combination/profile may be ordered separately as individual tests. Alliance Laboratories encourages clients to contact their Alliance representative if the testing configurations shown do not meet individual needs for any reason, or if some other combination of procedures is needed.

CPT CODES
CPT Codes listed are in accordance with Current Procedural Terminology, a publication of the American Medical Association. CPT codes are the responsibility of the billing party and are listed here for informational purposes. Correct coding may vary from one carrier to another. Alliance laboratories may bill specific carriers using codes other than what is shown.

• REQUISITION
• SAMPLE REPORT
• PROFILE/PANEL

EXPECTED TURNAROUND TIME 

5 Days 

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

SPECIMEN REQUIREMENTS 

SPECIMEN
Buccal Swab and Saliva

VOLUME
3 mL of saliva (minimum volume-1 mL of saliva)

CONTAINER
Dry Transport Container

STORAGE INSTRUCTIONS
Room Temp., Refrigerated (2-8 °C)

STABILITY REQUIREMENT
Room temp. 4 days, Refrigerated (2-8 °C) 7 days

TEST DETAILS

METHODOLOGY
PCR

REFERENCE RANGE 
Detected or Not Detected 

STATEMENT OF MEDICAL NECESSITY 
All ordered tests should be medically necessary for the diagnosis or detection of disease, illness, impairment, symptom, syndrome, or disorder and the results should be used in the medical management and treatment decisions for the patient. Alliance Laboratories requires ICD-10 codes with each order for lab testing and both the tests ordered, and the diagnosis should be documented in the provider’s medical record for the patient. Pharmacogenomics is essential for tailoring medication therapy to individual genetic profiles, enhancing efficacy, and minimizing adverse drug reactions. By understanding how a patient’s genetic makeup influences their response to specific drugs, clinicians can make informed decisions about prescribing medications, leading to more effective and safer treatments. For patients who are beginning a new medication regimen or have a history of inadequate response or adverse effects to medications, to tailor therapy based on their genetic profile. In patients with chronic conditions requiring
long-term medication management, where genetic factors may significantly impact drug metabolism and efficacy. The pharmacogenomics (PGX) panel is a crucial diagnostic tool for personalizing medication therapy, enhancing treatment efficacy, and reducing the risk of adverse drug reactions. By integrating genetic information into clinical decision-making, PGX panels support precision medicine and improve patient outcomes through individualized treatment plans. The United States Department of Health and Human Services, Office of Inspector General, takes the position that a provider who orders medically unnecessary tests may be subject to civil penalties.

PANELS AND PROFILES 
Alliance Laboratories offers Providers the convenience of ordering test combinations in a group at times with the flexibility to choose appropriate test(s) for individual patients. Providers should only order those tests that he or she believes are medically necessary for each patient, and a lesser inclusive profile or individual tests should be ordered if not all tests in the test combination/profile are medically necessary. All tests offered in a test
combination/profile may be ordered separately as individual tests. Alliance Laboratories encourages clients to contact their Alliance representative if the testing configuration shown do not meet individual needs for any reason, or if some other combination of procedures is needed.

CPT CODES
CPT Codes listed are in accordance with Current Procedural Terminology, a publication of the American Medical Association. CPT codes are the responsibility of the billing party and are listed here for informational purposes. Correct coding may vary from one carrier to another. Alliance laboratories may bill specific carriers using codes other than what is shown.

• REQUISITION
• SAMPLE REPORT
• PROFILE/PANEL

EXPECTED TURNAROUND TIME 

24-48 Hours 

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

SPECIMEN REQUIREMENTS 

SPECIMEN
Clean Catch Urine and Multi-test swab

VOLUME
3 mL of urine

CONTAINER
C&S Tube with preservative, Sterile Urine Transport Tube, Aptima Multi-test device

COLLECTION INSTRUCTIONS
Clean Catch

STORAGE INSTRUCTIONS 
Refrigerated (2-8 °C) for 7 days and at -70°C or lower for 14 days. Avoid repeated freezing and thawing. 

STABILITY REQUIREMENTS 
Refrigerated (2-8 °C) for 7 days and at -70°C or lower for 14 days. Avoid repeated freezing and thawing. 

TEST DETAILS

METHODOLOGY
PCR

REFERENCE RANGE 
Detected or Not Detected

STATEMENT OF MEDICAL NECESSITY 
Sexually transmitted diseases (STDs) represent a significant public health concern due to their potential to cause serious health complications if left untreated. STDs can lead to a range of issues including infertility, chronic pain, and increased susceptibility to HIV. Early detection and management are crucial for effective treatment and to prevent transmission to others. All
ordered tests should be medically necessary for the diagnosis or detection of disease, illness, impairment, symptom, syndrome, or disorder and the results should be used in the medical management and treatment decisions for the patient. Alliance Laboratories requires ICD-10 codes with each order for lab testing and both the tests ordered and the diagnosis should be
documented. The United States Department of Health and Human Services, Office of Inspector General, takes the position that a provider who orders medically unnecessary tests may be subject to civil penalties.

PANELS AND PROFILES
Alliance Laboratories offers Providers the convenience of ordering test combinations in a group at times with the flexibility to choose appropriate test(s) for individual patients. Providers should only order those tests that he or she believes are medically necessary for each patient, and a lesser inclusive profile or individual tests should be ordered if not all tests in the test combination/profile are medically necessary. All tests offered in a test combination/profile may be ordered separately as individual tests. Alliance Laboratories Sexually Transmitted Diseases (STDs) Panel consist of 14 organisms and 4 antibiotic resistance targets manufactured with the
fluidity to formulate custom panels. Alliance Laboratories encourages clients to contact their Alliance representative if the testing panel shown do not meet individual needs for any reason, or if some other combination of procedures is needed.

CPT CODES
CPT Codes listed are in accordance with Current Procedural Terminology, a publication of the American Medical Association. CPT codes are the responsibility of the billing party and are listed here for informational purposes. Correct coding may vary from one carrier to another. Alliance laboratories may bill specific carriers using codes other than what is shown.

EXPECTED TURNAROUND TIME 

24-48 Hours 

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

SPECIMEN REQUIREMENTS 

SPECIMEN
Urine

VOLUME
10 mL

CONTAINER
4ml aspirated volume to C&S tube

COLLECTION INSTRUCTIONS
Clean Catch 

STORAGE INSTRUCTIONS 
Room temperature for 24-48 hours, refrigerated (2-8°C) for 24-48 hours.

STABILITY REQUIREMENTS
Refrigerated (2-8°C) for 7 days

TEST DETAILS 

METHODOLOGY
PCR

REFERENCE RANGE 
Detected or Not Detected

STATEMENT OF MEDICAL NECESSITY
All ordered tests should be medically necessary for the diagnosis or detection of disease, illness, impairment, symptom, syndrome, or disorder and the results should be used in the medical management and treatment decisions for the patient. Alliance Laboratories requires ICD-10 codes with each order for lab testing and both the tests ordered, and the diagnosis should be documented in the provider’s medical record for the patient. Urinary tract infections (UTIs) are common infections that can significantly impact an individual’s health and quality of life. They can lead to serious complications such as pyelonephritis, sepsis, and renal damage if
not treated promptly. Early diagnosis and appropriate management are essential to alleviate symptoms, prevent progression, and reduce the risk of complications. The United States Department of Health and Human Services, Office of Inspector General, takes the position that a provider who orders medically unnecessary tests may be subject to civil penalties.

PANELS AND PROFILES
Alliance Laboratories offers Providers the convenience of ordering test combinations in a group at times with the flexibility to choose appropriate test(s) for individual patients. Providers should only order those tests that he or she believes are medically necessary for each patient, and a lesser inclusive profile or individual tests should be ordered if not all tests in the test combination/profile are medically necessary. All tests offered in a test combination/profile may be ordered separately as individual tests. Alliance Laboratories encourages clients to contact their Alliance Laboratories representative if the testing configurations shown do not meet individual needs for any reason, or if some other combination of procedures is needed.

CPT CODES
CPT Codes listed are in accordance with Current Procedural Terminology, a publication of the American Medical Association. CPT codes are the responsibility of the billing party and are listed here for informational purposes. Correct coding may vary from one carrier to another. Alliance laboratories may bill specific carriers using codes other than what is shown.

EXPECTED TURNAROUND TIME 

24-48 Hours 

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

SPECIMEN REQUIREMENTS 

SPECIMEN
Wound Swab

CONTAINER
Liquid Amies Medium with Polyster Flock Swab

STORAGE INSTRUCTIONS 
Room temperature for 24-48 hours and Refrigerated (2-8 °C) for 24-48 hours

STABILITY REQUIREMENTS 
Refrigerated (2-8 °C) for 7 days and at -70°C or lower for 14 days

TEST DETAILS

METHODOLOGY
PCR

REFERENCE RANGE 
Detected or Not Detected

ADDITIONAL INFORMATION

Each year millions of people suffer from nonhealing wounds, leading to unnecessary hospitalizations and lower-extremity amputations. The chronic wound epidemic is projected to grow annually because of an aging population with increased rates of obesity and diabetes. Patients with infected wounds can experience an abnormal healing process that can lead to longer-term care, additional medications, pain, stress, depression, hospitalization, function and mobility loss, and higher healthcare costs for healthcare organizations and patients alike. With molecular testing, not only can the type and percent of pathogens causing the infection to be visualized but, in many cases, the antimicrobial resistance can also be identified. With the power of molecular testing, the optimal medication therapy for the patient can be selected to improve treatment outcomes and reduce healthcare expenditure. Because efficiency and turnaround time are so important to physicians and their patients, the Applied Biosystems
ThermoFisher panel uses real-time polymerase chain reaction (RT PCR). Nonhealing wounds are not so much a disease as a symptom. Patients with nonhealing wounds are likely to be older adults, non-ambulatory or paralyzed, unable to provide self-care, and/or having dementia. Their wounds may occur as a result of unique medical conditions (e.g., sickle cell anemia, vasculitis); in association with immunosuppression (e.g., steroid use), renal impairment (e.g., calciphylaxis), autoimmune diseases (e.g., systemic lupus erythematosus), dermatologic diseases (e.g., epidermolysis bullosa), and age-related debility or paralysis (which can lead to pressure ulcers); result from peripheral neuropathy (e.g., diabetes); and occur in patients with peripheral arterial and venous disease (e.g., arterial and venous ulcers). Accurate and prompt identification and determination of wound pathogens is key to proper wound management for patients suffering from pathogenic infection. Molecular diagnostics holds significant potential for improving the management of chronic wounds and ultimately enhancing patient outcomes.
REFERENCES
1. Nussbaum SR, Carter MJ, Fife CE, et al. An economic evaluation of the impact, cost, and Medicare policy implications of chronic nonhealing wounds. Value Health 2018;21(1):27-32.
2. Rice J, Desai U, Ristovska L, et al. Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers. J Med Econ 2015;18(8):586-95.
3. Santema TB, Poyck PPC, Ubbink DT. Systematic review and meta-analysis of skin substitutes in the treatment of diabetic foot ulcers: highlights of a Cochrane systematic review. Wound Repair Regen 2016;24(4):737-44.
4. Landsman A, Rosines E, Houck A, et al. Characterization of a cryopreserved split- thickness human skin allograft—TheraSkin. Adv Skin Wound Care 2016;29:399-406.
5. Landsman AS, Cook J, Cook E, et al. A retrospective clinical study of 188 consecutive patients to examine the effectiveness of a biologically active cryopreserved human skin allograft (TheraSkin) on the treatment of diabetic foot ulcers and venous leg ulcers. Foot Ankle Spec 2011;4:29-41.
6. Adrian Barbul, MD; Helen Gelly, MD; and Arti Masturzo, MD, The Health Economic Impact of Living Cell Tissue Products in the Treatment of Chronic Wounds: A Retrospective Analysis of Medicare Claims Data

STATEMENT OF MEDICAL NECESSITY
All ordered tests should be medically necessary for the diagnosis or detection of disease, illness, impairment, symptom, syndrome, or disorder and the results should be used in the medical management and treatment decisions for the patient. Alliance Laboratories requires ICD-10 codes with each order for lab testing and both the tests ordered, and the diagnosis should be documented in the provider’s medical record for the patient. Wound infections can significantly impede healing, increase the risk of systemic infection, and lead to severe complications if not properly managed. A wound panel provides critical information about microbial etiology and antibiotic susceptibility, which is essential for tailoring effective treatment strategies. The use of a wound panel is a critical component of comprehensive wound management, allowing for precise diagnosis and effective treatment of infections. By identifying specific pathogens and their sensitivities, a wound panel supports targeted therapy, reduces the risk of complications, and promotes optimal healing. The United States Department of Health and Human Services, Office of Inspector General, takes the position that a provider who orders medically unnecessary tests may be subject to civil penalties.

PANELS AND PROFILES
Test Includes Antibiotic Resistance Test Menu
mecA
mcr-1
tetM
tetS
vanA
vanB
Sul1
Bacteria Targets
Acinetobacter baumannii
Clostridium perfringens
Clostridium tetanii
Corynebacter amycolatum
Corynebacter straitum
Enterococcus faecalis
Enterococcus faecium
Escherichia coli
Klebsiella pneumoniae
Morganella morganii
Proteus mirablis
Pseudomonas aeruginosa
Serratia marcescens
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus agalactiae
Streptococcus pneumoniae
Candida albicans
Candida glabrata
Candida parapsilosis
Candida tropicalis

Alliance Laboratories offers Providers the convenience of ordering test combinations in a group at times with the flexibility to choose appropriate test(s) for individual patients. Providers should only order those tests that he or she believes are medically necessary for each patient, and a lesser inclusive profile or individual tests should be ordered if not all tests in the test combination/profile are medically necessary. All tests offered in a test combination/profile may be ordered separately as individual tests. Alliance Laboratories encourages clients to contact their Alliance representative if the testing configurations shown do not meet individual needs for any reason, or if some other combination of procedures is needed.

CPT CODES
CPT Codes listed are in accordance with Current Procedural Terminology, a publication of the American Medical Association. CPT codes are the responsibility of the billing party and are listed here for informational purposes. Correct coding may vary from one carrier to another. Alliance laboratories may bill specific carriers using codes other than what is shown.